Breye Therapeutics raises €67.5 million in over-subscribed Series A financing
Breye Therapeutics ApS said it raised €67.5 million in an over-subscribed Series A round co-led by Mission Biocapital and existing investor Novo Holdings.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.